NOUV OTC
Nouveau Life Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +9900.0%
3Y: -0.0%
5Y: -85.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$17K
+0.0% ▲
Net Income
-$17K
+0.0% ▲
EPS (Diluted)
$0.00
+0.0% ▲
EBITDA
-$17K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2004 | FY2005 | FY2006 | FY2007 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $9K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $220K | $318K | $177K | $160K | $17K |
| Operating Expenses | $229K | $318K | $267K | $357K | $17K |
| Operating Income | $229K | $318K | $267K | $357K | -$17K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $0 | $313K | $266K | $348K | -$17K |
| Tax Expense | $542K | $83K | -$10K | $0 | $0 |
| Net Income | -$312K | -$401K | -$257K | -$357K | -$17K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.01 | $-0.02 | $-0.01 | $-0.01 | $0.00 |
| EBITDA | -$229K | -$200K | -$213K | -$214K | -$17K |
| Shares Outstanding | 22M | 24M | 26M | 28M | 6.66B |